Catheter Precision, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
Catheter Precision, Inc. (VTAK) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 35 shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2024-04-01
- Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2023-12-31 was -8.96K shares.
- Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2023-09-30 was 8.99K shares.
- Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2023-06-30 was 0.00 shares.
- Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2023-03-31 was 9.00 shares.
- Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2023 was 35.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month |
|---|---|---|---|---|
| 2023-12-31 | -8.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 26.00 shares derived: sum of 2 quarters · filed 2024-04-01 | 26.00 shares derived: sum of 3 quarters · filed 2024-04-01 | 35.00 shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 8.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-21 | 8.99K shares derived: sum of 2 quarters · filed 2023-12-21 | 9.00K shares 10-Q · filed 2023-12-21 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | 9.00 shares 10-Q · filed 2023-12-15 | ||
| 2023-03-31 | 9.00 shares 10-Q · filed 2023-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |